2025年4月15日-18日，日本PMDA专家组对精晶药业开展药品GMP现场审计。精晶药业作为专注高品质仿制原料药、氨基酸及维生素系列产品研发、生产和销售的国家高新技术创新示范企业，以规范化的质量体系与高效生产管理，顺...
4月15日 市政府副秘书长侯子君及北京证券交易所北方基地副主任苏邗在县、乡政府相关领导陪同下，一行莅临精晶药业，就公司上市工作开展调研指导。董事长李斌水携相关负责人予以热情接待。 座谈会上，董事长李斌水系统...
2025年4月11日，珠海优润医药科技有限公司创始人左总率团队到访精晶药业，与公司总经理马静及核心团队展开深入交流。双方就阿维巴坦钠品种合作进展进行研讨，并就品种项目合作前景展开探讨。自建立合作关系以来，双方...
精晶药业与北京化工大学正式签署战略合作协议，携手共建“原料药绿色制备联合研发中心”。双方以绿色原料药制备技术革新为核心，围绕低碳工艺优化、高附加值原料药品种开发等方向达成多项合作意向，致力于打造产学研...
Jingjing Pharmaceutical - Hazardous Waste Management System.pdf
Jingjing Pharmaceutical Xingtai Food Additives Branch 2025 Hazardous Waste Management Plan.pdf
2023-032 Jingjing Pharmaceutical: Announcement on Application for Public Offering of Shares and Listing on North Exchange Tutoring Filing and Progress.pdf
Jingjing Pharmaceutical - Hazardous Waste Training Management Measures.pdf
Facing Crisis with Courage, Being Guardians in Wind and Rain. Since July 29, affected by Typhoon Doksuri, continuous heavy rainfall has caused severe waterlogging in surrounding villages.
Recently, Hebei Provincial Department of Science and Technology announced the 2022 list of Key Academician Cooperation Units in Hebei Province, and Jingjing Pharmaceutical was listed with its professional technical capabilities.